Update on central precocious puberty: from etiologies to outcomes

References

• Nebesio TD, Eugster EA. Current concepts in normal and abnormal puberty. Curr Probl Pediatr Adolesc Health Care. 2007;37:50–72.
   PubMedGoogle Scholar
• Carel JC, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123:e752–62.
   PubMed Web of Science ®Google Scholar
• Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013;98:98–207.
   Web of Science ®Google Scholar
• Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985;107:317–329.
   PubMed Web of Science ®Google Scholar
• Soriano-Guillen L, Corripio R, Labarta JI, et al. Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration. J Clin Endocrinol Metab. 2010;95:4305–4313.
   PubMed Web of Science ®Google Scholar
• Lee PA, Neely EK, Fuqua J, et al. Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study. Int J Pediatr Endocrinol. 2011;2011:7.
   PubMedGoogle Scholar
• Choi KH, Chung SJ, Kang MJ, et al. Boys with precocious or early puberty: incidence of pathological brain magnetic resonance imaging findings and factors related to newly developed brain lesions. Ann Pediatr Endocrinol Metab. 2013;18:183–190.
   PubMedGoogle Scholar
• Alikasifoglu A, Vuralli D, Gonc EN, et al. Changing etiological trends in male precocious puberty: evaluation of 100 cases with central precocious puberty over the last decade. Horm Res Paediatr. 2015;83(5):340–344.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim J, Yang A, et al. Etiological trends in male central precocious puberty. Ann Pediatr Endocrinol Metab. 2018 Jun;23(2):75–80.
   PubMedGoogle Scholar
• de Vries L, Kauschansky A, Shohat M, et al. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab. 2004;89:1794–1800.
   PubMed Web of Science ®Google Scholar
• Rohn R, Rousonelos G. Familial sexual precocity. Am J Dis Child. 1986;140:741–742.
   PubMedGoogle Scholar
• Teles MG, Bianco SD, Brito VN, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med. 2008;358:709–715.
   PubMed Web of Science ®Google Scholar
• Luan X, Yu H, Wei X, et al. GPR54 polymorphisms in Chinese girls with central precocious puberty. Neuroendocrinology. 2007;86:77–83.
   PubMed Web of Science ®Google Scholar
• Silveira LG, Noel SD, Silveira-Neto AP, et al. Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab. 2010;95:2276–2280.
   PubMed Web of Science ®Google Scholar
• Abreu AP, Dauber A, Macedo DB, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368:2467–2475.
   PubMed Web of Science ®Google Scholar
• Settas N, Dacou-Voutetakis C, Karantza M, et al. Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene. J Clin Endocrinol Metab. 2014;99:E647–51.
   PubMed Web of Science ®Google Scholar
• Macedo DB, Abreu AP, Reis AC, et al. Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. J Clin Endocrinol Metab. 2014;99:E1097–103.
   PubMed Web of Science ®Google Scholar
• Dauber A, Cunha-Silva M, Macedo DB, et al. Paternally inherited DLK1 deletion associated with familial central precocious puberty. J Clin Endocrinol Metab. 2017;102:1557e67.
   Web of Science ®Google Scholar
• Zhao Y, Chen T, Zhou Y, et al. An association study between the genetic polymorphisms within GnRHI, LHbeta and FSHbeta genes and central precocious puberty in Chinese girls. Neurosci Lett. 2010;486:188–192.
   PubMed Web of Science ®Google Scholar
• Parent AS, Matagne V, Westphal M, et al. Gene expression profiling of hypothalamic hamartomas: a search for genes associated with central precocious puberty. Horm Res. 2008;69:114–123.
   PubMedGoogle Scholar
• Houk CP, Kunselman AR, Lee PA. The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate. J Pediatr Endocrinol Metab. 2008;21:1113–1118.
   PubMed Web of Science ®Google Scholar
• Yazdani P, Lin Y, Raman V, et al. A single sample GnRHa stimulation test in the diagnosis of precocious puberty. Int J Pediatr Endocrinol. 2012;2012:23.
   PubMedGoogle Scholar
• Lee PA. Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med. 1994;148:369e76.
   Google Scholar
• Carretto F, Salinas-Vert I, Granada-Yvern ML, et al. The usefulness of the leuprolide stimulation test as a diagnostic method of idiopathic central precocious puberty in girls. Horm Metab Res. 2014;46:959e63.
   Web of Science ®Google Scholar
• Oerter KE, Uriarte MM, Rose SR, et al. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab. 1990;71:1251e8.
   Web of Science ®Google Scholar
• Houk CP, Kunselman AR, Lee PA. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls. Pediatrics. 2009;123:e1059–63.
   PubMed Web of Science ®Google Scholar
• Neely EK, Wilson DM, Lee PA, et al. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr. 1995;127:47–52.
   PubMed Web of Science ®Google Scholar
• Eksioglu AS, Yilmaz S, Cetinkaya S, et al. Value of pelvic sonography in the diagnosis of various forms of precocious puberty in girls. J Clin Ultrasound. 2013;41:84–93.
   PubMed Web of Science ®Google Scholar
• de Vries L, Horev G, Schwartz M, et al. Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrinol. 2006;154:891.
   PubMed Web of Science ®Google Scholar
• Badouraki M, Christoforidis A, Economou I, et al. Evaluation of pelvic ultrasonography in the diagnosis and differentiation of various forms of sexual precocity in girls. Ultrasound Obstet Gynecol. 2008;32:819.
   PubMed Web of Science ®Google Scholar
• Pienkowski C, Cartault A, Carfagna L, et al. Ovarian cysts in prepubertal girls. Endocr Dev. 2012;22:101–111.
   PubMedGoogle Scholar
• DeSanctis V, Corrias A, Rizzo V, et al. Etiology of central precocious puberty in males: the results of the Italian study group for physiopathology of puberty. J Pediatr Endocrinol Metab. 2000;13:687–693.
   PubMed Web of Science ®Google Scholar
• Atta I, Laghari TM, Khan YN, et al. Precocious puberty in children. J Coll Physicians Surg Pak. 2015;25:124–128.
   PubMed Web of Science ®Google Scholar
• Bridges NA, Christopher JA, Hindmarsh PC, et al. Sexual precocity: sex incidence and aetiology. Arch Dis Child. 1994;70:116–118.
   PubMed Web of Science ®Google Scholar
• Chalumeau M, Chemaitilly W, Trivin C, et al. Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics. 2002;109:61–67.
   PubMed Web of Science ®Google Scholar
• Pedicelli S, Alessio P, Scirè G, et al. Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 years. J Clin Endocrinol Metab. 2014;99:4455–4461.
   PubMed Web of Science ®Google Scholar
• Cantas-Orsdemir S, Garb JL, Allen HF. Prevalence of cranial MRI findings in girls with central precocious puberty: a systematic review and meta-analysis. J Pediatr Endocrinol Metab. 2018 Jul 26;31:701–710.
   PubMed Web of Science ®Google Scholar
• Bereket A. A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty. J Clin Res Pediatr Endocrinol. 2017 Dec 30;9(Suppl 2):33–48.
   PubMedGoogle Scholar
• Klein KO, Barnes KM, Jones JV, et al. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab. 2001;86:4711e6.
   Web of Science ®Google Scholar
• Watson SE, Greene A, Lewis K, et al. Bird’s eye view of GnRH analog use in a pediatric endocrinology referral center. Endocr Pract. 2015;21:586–589.
   PubMed Web of Science ®Google Scholar
• Mul D, Bertelloni S, Carel JC, et al. Effect of gonadotropin releasing hormone agonist treatment in boys with central precocious puberty: final height results. Horm Res. 2002;58:1–7.
   PubMedGoogle Scholar
• Kaplowitz P, Bloch C. Section on endocrinology, American academy of pediatrics. Evaluation and referral of children with signs of early puberty. Pediatrics. 2016;137(1):1-6.
   Google Scholar
• Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab. 1999;84:415.
   PubMed Web of Science ®Google Scholar
• Lazar L, Pertzelan A, Weintrob N, et al. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab. 2001;86:4127.
   PubMed Web of Science ®Google Scholar
• Bar A, Linder B, Sobel EH, et al. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995;126:955.
   PubMed Web of Science ®Google Scholar
• Nacinovich R, Buzi F, Oggiano S, et al. Body experiences and psychopathology in idiopathic central precocious and early puberty. Minerva Pediatr. 2016;68:11–18.
   PubMed Web of Science ®Google Scholar
• Sonis WA, Comite F, Blue J, et al. Behavior problems and social competence in girls with true precocious puberty. J Pediatr. 1985;106:156–160.
   PubMed Web of Science ®Google Scholar
• Jackson PL, Ott MJ. Perceived self-esteem among girls diagnosed with precocious puberty. J Pediatr Nurs. 1990;5:190–203.
   PubMedGoogle Scholar
• Blumenthal H, Leen-Feldner EW, Babson KA, et al. Elevated social anxiety among early maturing girls. Dev Psychol. 2011;47:1133–1140.
   PubMed Web of Science ®Google Scholar
• Kaltiala-Heino R, Marttunen M, Rantanen P, et al. Early puberty is associated with mental health problems in middle adolescence. Soc Sci Med. 2003;57:1055e64.
   Web of Science ®Google Scholar
• Ehrhardt AA, Meyer-Balhlburg HF, Bell JJ, et al. Idiopathic precocious puberty in girls: psychiatric follow-up in adolescence. J Am Acad Child Adolesc Psychiatry. 1984;23:23–33.
   Web of Science ®Google Scholar
• Sonis WA, Comite F, Pescovitz OH, et al. Biobehavioral aspects of precocious puberty. J Am Acad Child Psychiatry. 1986;25:674–679.
   PubMedGoogle Scholar
• Comite F, Cassorla F, Barnes KM, et al. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height. JAMA. 1986;255:2613–2616.
   PubMed Web of Science ®Google Scholar
• Carel JC, Blumberg J, Seymour C, et al. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. Eur J Endocrinol. 2006;154:119e24.
   Web of Science ®Google Scholar
• Lee PA, Klein K, Mauras N, et al. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty. J Clin Endocrinol Metab. 2012;97:1572e80.
   Web of Science ®Google Scholar
• Fuld K, Chi C, Neely EK. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty. J Pediatr. 2011;159(6):982–987.
   PubMed Web of Science ®Google Scholar
• Duarnd A, Tauber M, Patel B, et al. Meta-analysis of paediatric patients with central precocious puberty treated with intramuscular triptorelin 11.25 mg 3-month prolonged-release formulation. Horm Res Paediatr. 2017;87:224e32.
   Web of Science ®Google Scholar
• Klein K, Yang J, Aisenberg J, et al. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty. J Pediatr Endocrinol Metab. 2016;29:1241e8.
   Web of Science ®Google Scholar
• Lewis KA, Eugster EA. Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty. Drug Des Dev Ther. 2009;3:1e5.
   Web of Science ®Google Scholar
• Hirsch HJ, Gillis D, Strich D, et al. The histrelin implant: a novel treatment for central precocious puberty. Pediatrics. 2005;116:e798–802.
   PubMed Web of Science ®Google Scholar
• Silverman LA, Neely EK, Kletter GB, et al. Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty: a final report of a phase 3 multicenter trial. J Clin Endocrinol Metab. 2015;100:2354–2363.
   PubMed Web of Science ®Google Scholar
• Eugster EA, Clarke W, Kletter GB, et al. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab. 2007;92:1697–1704.
   PubMed Web of Science ®Google Scholar
• Lewis KA, Goldyn AK, West KW, et al. A single histrelin implant is effective for 2 years for treatment of central precocious puberty. J Pediatr. 2013;163:1214–1216.
   PubMed Web of Science ®Google Scholar
• Lewis KA, Eugster EA. Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty. J Pediatr. 2013 Mar;162:562–565.
   PubMed Web of Science ®Google Scholar
• Pasquino AM, Pucarelli I, Accardo F, et al. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab. 2008;93:190–195.
   PubMed Web of Science ®Google Scholar
• Magiakou MA, Manousaki D, Papadaki M, et al. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab. 2010;95:109–117.
   PubMed Web of Science ®Google Scholar
• Poomthavorn P, Suphasit R, Mahachoklertwattana P. Adult height, body mass index and time of menarche of girls with id-iopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol Endocrinol. 2011;27:524–528.
   PubMed Web of Science ®Google Scholar
• Lazar L, Meyerovitch J, de Vries L, et al. Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades. Clin Endocrinol (Oxf). 2014 Apr;80:570–576.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Niimi H, Matsuo N, et al. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central precocious puberty. J Clin Endocrinol Metab. 2005;90:1371–1376.
   PubMed Web of Science ®Google Scholar
• Bertelloni S, Baroncelli GI, Ferdeghini M, et al. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. Eur J Pediatr. 2000;159:369–374.
   PubMed Web of Science ®Google Scholar
• Fisher MM, Lemay D, Eugster EA. Resumption of puberty in girls and boys following removal of the histrelin implant. J Paediatr. 2014;164:912–916.
   PubMed Web of Science ®Google Scholar